Arayne M Saeed, Sultana Najma, Zaman Rana Kamran
Department of Chemistry, University of Karachi.
Pak J Pharm Sci. 2004 Jul;17(2):41-56.
The in vitro availability studies of glibenclamide in presence of commonly used antacids are present in this paper. Glibenclamide is used for the treatment of Non-Insulin dependent diabetes mellitus. It is a sulfonylurea derivative. Antacids are prescribed to encounter gastric acidity etc. These studies were carried out in simulated gastric juice and in buffer of pH 7.4 at 37 and 48 degrees C. Aluminum hydroxide, aluminum trisilicate, magnesium oxide, magnesium trisilicate, sodium bicarbonate, calcium carbonate, magaldrate and simethicone (2,4-dimethoxypolysiloxane) antacids were used in these studies. It has been observed that in case of magnesium oxide, magnesium trisilicate and sodium bicarbonate, availability of glibenclamide was enhanced while in rest of the antacids retarded the availability of glibenclamide.
本文介绍了在常用抗酸剂存在的情况下格列本脲的体外溶出度研究。格列本脲用于治疗非胰岛素依赖型糖尿病。它是一种磺酰脲类衍生物。抗酸剂用于缓解胃酸过多等问题。这些研究在模拟胃液和pH值为7.4的缓冲液中于37℃和48℃下进行。本研究使用了氢氧化铝、三硅酸铝、氧化镁、三硅酸镁、碳酸氢钠、碳酸钙、铝镁加和西甲硅油(2,4 - 二甲氧基聚硅氧烷)等抗酸剂。据观察,在氧化镁、三硅酸镁和碳酸氢钠的情况下,格列本脲的溶出度提高,而在其他抗酸剂存在时,格列本脲的溶出度受到抑制。